In addition, miR-188-5p could also inhibit the expression of LAPTM4B by binding to its 3’-UTR region, thus inhibiting cell proliferation and invasion in prostate cancer (Figure 2) (64). Here, LAPTM4B is linked to prostate carcinoma.